Why Evolution Still Matters for Cancer — Insights from Across the Animal Kingdom A big paper from our team in Cancer Discovery
Athena Aktipis
Substack·2026
Why Evolution Still Matters for Cancer — Insights from Across the Animal Kingdom
A big paper from our team in Cancer Discovery (https://aacrjournals.org/cancerdiscovery/article/15/1/227/750844/Cancer-Prevalence-across-VertebratesCancer-across) looks at cancer prevalence across vertebrate species. This is the largest study of its kind, using over 16,000 veterinary necropsy records from 292 species of amphibians, reptiles, birds, and mammals to understand how often different animals actually get cancer and why that might be.
The results are fascinating, and they help us see cancer not just as a human disease but as an evolutionary problem that all multicellular life has had to deal with. Across the vertebrates, rates of both benign tumors (neoplasia) and malignant cancers vary widely. On average, larger animals and those with higher somatic mutation rates tend to show higher cancer prevalence, while species with long gestation times tend to show lower rates. This challenges some long-held ideas about how body size and lifespan shape cancer risk, and opens up new questions about how different evolutionary strategies affect cancer susceptibility.
One of the most exciting things about this dataset is the opportunity it gives us to identify species that get less cancer than expected, and to study what makes them special. Those biological mechanisms could turn out to be powerful models for cancer suppression and prevention in humans.
If you’ve read The Cheating Cell (https://www.amazon.com/Cheating-Cell-Evolution-Understand-Cancer/dp/0691163847), some of these ideas will feel familiar. In that book I talk about cancer as a breakdown of cooperation in multicellular organisms: cells that stop playing by the rules and begin behaving like independent proliferators. But evolution didn’t just create multicellularity and walk away. Over hundreds of millions of years, species have evolved diverse ways to keep cellular cooperation stable and, in some cases, resist cancer remarkably well. Studies like this one help us see that variation in the wild, and they give us clues about the mechanisms that preserve cooperation even in large, long-lived bodies.
For example, while mammals as a group tend to have higher neoplasia and cancer prevalence than amphibians, reptiles, or birds, there are notable outliers on both ends of the spectrum. Some smaller species show unexpectedly high rates, and some large-bodied animals appear surprisingly resistant. Understanding why these differences exist may unlock strategies for improving cancer prevention and treatment.
This paper is a reminder that cancer is both a clinical challenge and an evolutionary problem, shaped by the same forces that govern cooperation and conflict in multicellular life. When we look across species instead of just within humans or traditional lab animals, we see patterns that would otherwise remain hidden. These patterns reflect life history traits shaped by natural selection — gestation times, body size, metabolism, and perhaps even immune system strategies that have evolved to manage cellular conflict.
One takeaway from this study is that the very traits that make us human — our bodies, lifespans, developmental timing — have deep evolutionary roots that continue to influence cancer risk. By learning from other branches of life’s tree, we gain evolutionary perspective that can inform both basic science and medical strategies.
If The Cheating Cell is about the conflict and cooperation within our own cells, this paper extends that lens out across the vertebrate world, showing how evolution’s solutions can be both diverse and deeply informative.